Minus80Freezers
Don'tGrowOnTrees
From the European Medicines Agency today:
EMA’s human medicines committee (CHMP) has recommended a change to the approved storage conditions of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, that will facilitate the handling of the vaccine in vaccination centres across the European Union (EU).
This change extends the approved storage period of the unopened thawed vial at 2-8°C (i.e. in a normal fridge after taking out of deep-freeze conditions) from five days to one month(31 days)...
Here are the details:
If taken up in Canada this change could significantly simplify the distribution problem, especially to remote areas and smaller centers. It will also decrease waste due to spoilage.
EMA’s human medicines committee (CHMP) has recommended a change to the approved storage conditions of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, that will facilitate the handling of the vaccine in vaccination centres across the European Union (EU).
This change extends the approved storage period of the unopened thawed vial at 2-8°C (i.e. in a normal fridge after taking out of deep-freeze conditions) from five days to one month(31 days)...
Here are the details:
If taken up in Canada this change could significantly simplify the distribution problem, especially to remote areas and smaller centers. It will also decrease waste due to spoilage.
No comments:
Post a Comment